Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$6.44
−$0.01 · -0.16%
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Previous close
$6.44
−$0.01 · -0.16%
Pre-market
$6.51
+$0.07 · +1.09%
Oct 8, 4:44 AM ET
Regular session · ET · Market data may be delayed.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Day range
Current $6.44
52-week range
Current $6.44
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
47
Fair Value
Sentiment
52
Mixed
Risk
68
High Risk
Momentum
26
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Day range
Current $6.44
52-week range
Current $6.44
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 129.46M USD | 128.87M USD | 128.26M USD | 103.27M USD | 111.27M USD |
| Cost of goods sold | 88.85M USD | 88.57M USD | 86.41M USD | 75.28M USD | 72.2M USD |
| Gross profit | 40.61M USD | 40.3M USD | 41.85M USD | 27.99M USD | 39.07M USD |
| Research and development | 8.5M USD | 8.26M USD | 8.58M USD | 8.74M USD | 7.84M USD |
| Selling, general, and administrative | 33.35M USD | 44.05M USD | 40.46M USD | 38.97M USD | 34.66M USD |
| Operating expenses | 41.87M USD | 57.54M USD | 50.69M USD | 49.78M USD | 50.86M USD |
| Interest income | — | — | — | 68K USD | 81K USD |
| Interest expense | −2.21M USD | 21.84M USD | 18.09M USD | 17.65M USD | 15.55M USD |
| Depreciation and amortization | 9.5M USD | 8.03M USD | 7.95M USD | 13.18M USD | 18.06M USD |
| Operating income | −1.26M USD | −17.25M USD | −8.84M USD | −21.8M USD | −11.79M USD |
| Net income | −30.79M USD | −38.72M USD | 12.01M USD | −99.56M USD | −116.72M USD |
Company facts updated Oct 8, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM4.77M0.01%78.56B USD0.19%$277.7-1.29%
Vanguard Morningstar Total Stock Market ETFVTI3.67M0.00%2.3T USD0.03%$381.03-0.40%
Vanguard Extended Market ETFVXF1.94M0.00%95.4B USD0.05%$233.49-1.56%
Vanguard Russell 2000 ETFVTWO729.42K0.00%18B USD0.06%$112.21-1.26%
iShares Micro-Cap ETFIWC579.93K0.04%1.33B USD0.60%$183.36-1.09%
Vanguard Russell 2000 Value ETFVTWV110.63K0.01%1.4B USD0.06%$184.96-1.15%
iShares Russell 2500 ETFSMMD100.42K0.00%4.06B USD0.23%$85.85-1.46%
Global X - Russell 2000 ETFRSSL87.62K0.01%1.43B USD0.08%$108.69-1.28%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCVanguard Russell 2000 Value ETFVTWViShares Russell 2500 ETFSMMDGlobal X - Russell 2000 ETFRSSLAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
